Cardinal Health is highlighted as one of Wall Street's favorite stocks with competitive advantages, based on analyst price targets implying over 20% upside. However, the article cautions that such forecasts may be overly optimistic due to analysts' potential conflicts of interest. The company is being evaluated within the healthcare providers and services sector, with quarterly earnings results providing a progress check.